Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Antithrombin inhibition using nanobodies to correct bleeding in hemophilia.

O'Sullivan JM, O'Donnell JS.

EMBO Mol Med. 2020 Mar 25:e12143. doi: 10.15252/emmm.202012143. [Epub ahead of print]

2.

Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation.

Fazavana J, Brophy TM, Chion A, Cooke N, Terraube V, Cohen J, Parng C, Pittman D, Cunningham O, Lambert M, O'Donnell JS, O'Sullivan JM.

J Thromb Haemost. 2020 Feb 28. doi: 10.1111/jth.14785. [Epub ahead of print]

PMID:
32108991
3.

Report of the 2018-2019 Research and Graduate Affairs Committee.

O'Donnell JM, Anand S, Brown SD, Fuji KT, Guy RK, Kawaguchi-Suzuki M, Meier KE, Nelson CE, Vyas A, Block KF, Farrell DF.

Am J Pharm Educ. 2019 Dec;83(10):7595. doi: 10.5688/ajpe7595.

4.

Perioperative management of patients with von Willebrand disease.

O'Donnell JS, Lavin M.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):604-609. doi: 10.1182/hematology.2019000065.

PMID:
31808837
5.

An international survey to inform priorities for new guidelines on von Willebrand disease.

Kalot MA, Al-Khatib M, Connell NT, Flood V, Brignardello-Petersen R, James P, Mustafa RA; VWD working group.

Haemophilia. 2020 Jan;26(1):106-116. doi: 10.1111/hae.13881. Epub 2019 Nov 26.

PMID:
31769905
6.

Revealing biases in the sampling of ecological interaction networks.

de Aguiar MAM, Newman EA, Pires MM, Yeakel JD, Boettiger C, Burkle LA, Gravel D, Guimarães PR Jr, O'Donnell JL, Poisot T, Fortin MJ, Hembry DH.

PeerJ. 2019 Sep 2;7:e7566. doi: 10.7717/peerj.7566. eCollection 2019.

7.

Protection from Amyloid β Peptide-Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor.

Cui SY, Yang MX, Zhang YH, Zheng V, Zhang HT, Gurney ME, Xu Y, O'Donnell JM.

J Pharmacol Exp Ther. 2019 Nov;371(2):250-259. doi: 10.1124/jpet.119.259986. Epub 2019 Sep 5.

8.

Single housing-induced effects on cognitive impairment and depression-like behavior in male and female mice involve neuroplasticity-related signaling.

Liu N, Wang Y, An AY, Banker C, Qian YH, O'Donnell JM.

Eur J Neurosci. 2019 Aug 31. doi: 10.1111/ejn.14565. [Epub ahead of print]

PMID:
31471985
9.

Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia.

Ward CM, Andrews RK; ISTH State of the Art Speakers.

Res Pract Thromb Haemost. 2019 Jul 5;3(3):431-497. doi: 10.1002/rth2.12225. eCollection 2019 Jul. Review.

10.

Beyond Medical Cannabis: Considerations for Updates to Hospital Policies and Procedures.

O'Donnell J, Vogenberg FR, Vogenberg FR.

P T. 2019 Jul;44(7):410-433.

11.

von Willebrand factor promotes wound healing.

O'Donnell JS, O'Sullivan JM.

Blood. 2019 Jun 13;133(24):2553-2555. doi: 10.1182/blood.2019001175. No abstract available.

PMID:
31196875
12.

Chemoradiotherapy-related carotid artery inflammation in head and neck cancer patients quantified by [18F]FDG PET/CT.

Chen X, Zheng Y, Tatsuoka C, Muzic RF Jr, Okoye CC, O'Donnell JK, Zidar D, Avril N, Oliveira GH, Liu H, Bucher J, Machtay M, Yao M, Dorth JA.

Oral Oncol. 2019 Jun;93:101-106. doi: 10.1016/j.oraloncology.2019.04.008. Epub 2019 May 1.

PMID:
31109689
13.

von Willebrand factor sialylation-A critical regulator of biological function.

Ward S, O'Sullivan JM, O'Donnell JS.

J Thromb Haemost. 2019 Jul;17(7):1018-1029. doi: 10.1111/jth.14471. Epub 2019 May 30. Review.

PMID:
31055873
14.

The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition.

Zhu X, Li W, Li Y, Xu W, Yuan Y, Zheng V, Zhang H, O'Donnell JM, Xu Y, Yin X.

Neuropharmacology. 2019 Jul 15;153:20-31. doi: 10.1016/j.neuropharm.2019.04.022. Epub 2019 Apr 24.

PMID:
31026437
15.

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.

Gurney ME, Nugent RA, Mo X, Sindac JA, Hagen TJ, Fox D 3rd, O'Donnell JM, Zhang C, Xu Y, Zhang HT, Groppi VE, Bailie M, White RE, Romero DL, Vellekoop AS, Walker JR, Surman MD, Zhu L, Campbell RF.

J Med Chem. 2019 May 23;62(10):4884-4901. doi: 10.1021/acs.jmedchem.9b00193. Epub 2019 Apr 23.

PMID:
31013090
16.

Advances in understanding the molecular mechanisms that maintain normal haemostasis.

O'Donnell JS, O'Sullivan JM, Preston RJS.

Br J Haematol. 2019 Jul;186(1):24-36. doi: 10.1111/bjh.15872. Epub 2019 Mar 28. Review.

PMID:
30919939
17.

Advances in understanding the molecular mechanisms of venous thrombosis.

Preston RJS, O'Sullivan JM, O'Donnell JS.

Br J Haematol. 2019 Jul;186(1):13-23. doi: 10.1111/bjh.15869. Epub 2019 Mar 24. Review.

PMID:
30906986
18.

Uncommon Presentation of Metastatic Squamous Cell Carcinoma of the Skin and Treatment Challenges.

Pandey A, Liaukovich M, Joshi K, Avezbakiyev BI, O'Donnell JE.

Am J Case Rep. 2019 Mar 6;20:294-299. doi: 10.12659/AJCR.913488.

19.

Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.

Chen L, Cui S, Yu H, Li G, Liu N, Wu Q, Zhang HT, O'Donnell JM, Wang G, Xu Y.

J Psychopharmacol. 2019 May;33(5):568-576. doi: 10.1177/0269881119832753. Epub 2019 Mar 5.

PMID:
30835157
20.

Supplemental Content

Loading ...
Support Center